Literature DB >> 6215651

A small hypervariable segment in the variable domain of an immunoglobulin light chain stimulates formation of anti-idiotypic suppressor T cells.

N Sakato, M Semma, H N Eisen, T Azuma.   

Abstract

The induction in BALB/c mice of suppressor T cells that block a delayed-type hypersensitivity (DTH) response to the idiotype of M315, a myeloma protein of BALB/c origin, was examined with a variety of immunoglobulin chains and fragments whose amino acid sequences are known. Normal BALB/c mice receiving either the light chain of M315 (L315, lambda 2 isotype) or the variable (V) domain of this chain prior to sensitization with M315 showed marked suppression of DTH to the M315 idiotype. In contrast, neither the heavy chain nor the variable domain of the heavy chain of M315 affected the DTH response. Two other lambda 2 chains were tested and they also failed to suppress DTH to M315. Comparison of amino acid sequences in the three lambda 2 chains indicates that in L315 at most four V region amino acid substitutions (each resulting from a somatic mutation in the V lambda 2 germ-line gene) determine the specificity of the T-cell suppressor pathway. One of the four is in the framework and probably of negligible importance; the other three, however, are all clustered in the third hypervariable loop of the L315 V domain. The tertiary structure of L315 may also be essential, because disruption of intrachain disulfide bonds abolished the ability of the chain to induce suppression.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6215651      PMCID: PMC346904          DOI: 10.1073/pnas.79.17.5396

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  An active antibody fragment (Fv) composed of the variable portions of heavy and light chains.

Authors:  J Hochman; D Inbar; D Givol
Journal:  Biochemistry       Date:  1973-03-13       Impact factor: 3.162

2.  Quantitation of conformational changes on chemical modification of proteins: use of succinylated proteins as a model.

Authors:  A F Habeeb
Journal:  Arch Biochem Biophys       Date:  1967-09       Impact factor: 4.013

3.  Recovery of binding activity in reconstituted mouse myeloma proteins.

Authors:  S H Bridges; J R Little
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

4.  Similar idiotypic specificities in immunoglobulin fractions with different antibody functions or even without detectable antibody function.

Authors:  J Oudin; P A Cazenave
Journal:  Proc Natl Acad Sci U S A       Date:  1971-10       Impact factor: 11.205

5.  Affinity labeling of a mouse myeloma protein which binds nitrophenyl ligands. Kinetics of labeling and isolation of a labeled peptide.

Authors:  E J Goetzl; H Metzger
Journal:  Biochemistry       Date:  1970-03-03       Impact factor: 3.162

6.  Amino acid sequence of the light chain of a mouse myeloma protein (MOPC-315).

Authors:  E S Dugan; R A Bradshaw; E S Simms; H N Eisen
Journal:  Biochemistry       Date:  1973-12-18       Impact factor: 3.162

7.  Affinity labeling of a phosphorylcholine binding mouse myeloma protein.

Authors:  B Chesebro; H Metzger
Journal:  Biochemistry       Date:  1972-02-29       Impact factor: 3.162

8.  Crystallization with hapten of the Fab' fragment from a mouse IgA myeloma protein with antidinitrophenyl activity.

Authors:  D Inbar; M Rotman; D Givol
Journal:  J Biol Chem       Date:  1971-10-25       Impact factor: 5.157

9.  Myeloma proteins as tumor-specific transplantation antigens.

Authors:  R G Lynch; R J Graff; S Sirisinha; E S Simms; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

10.  Autoimmune-like antibodies to the ligand-binding sites of myeloma proteins.

Authors:  S Sirisinha; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1971-12       Impact factor: 11.205

View more
  9 in total

1.  Activation of idiotype-specific CD4+ T-cell line: cellular processing of exogenous self-immunoglobulin.

Authors:  N Sakato; P Rugdech; T Yoda; A Ota; Y Zhao; M Semma; Y Suzuki; H Fujio
Journal:  Immunology       Date:  1990-10       Impact factor: 7.397

2.  Immune response to myeloma cells and idiotypes.

Authors:  A K Abbas
Journal:  Surv Immunol Res       Date:  1983

3.  Donor Igh-linked genetic control of allotype-specific antibody response.

Authors:  R Inagi; T Yoshida; K Isobe; I Nakashima
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

4.  Clinical relapse in systemic lupus erythematosus: correlation with antecedent elevation of urinary free light-chain immunoglobulin.

Authors:  J E Hopper; W Sequeira; J Martellotto; E Papagiannes; L Perna; J L Skosey
Journal:  J Clin Immunol       Date:  1989-07       Impact factor: 8.317

5.  Diversity at the variable-joining region boundary of lambda light chains has a pronounced effect on immunoglobulin ligand-binding activity.

Authors:  T Azuma; V Igras; E B Reilly; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

6.  Monoclonal anti-VH141 antibodies that specifically recognize the heavy chain variable region of, and are closely related to, MOPC141 myeloma protein whose VH gene belongs to VHQ52 family.

Authors:  Y Minami; N Sakato; T Komori; S Kishimoto; H Sugiyama
Journal:  Immunology       Date:  1991-04       Impact factor: 7.397

Review 7.  The paradoxical functions of B cells and antibodies in transplantation.

Authors:  Marilia I Cascalho; Brian J Chen; Mandy Kain; Jeffrey L Platt
Journal:  J Immunol       Date:  2013-02-01       Impact factor: 5.422

8.  Fine specificity analysis of idiotype-specific suppressor factors that block a delayed-type hypersensitivity response to M315: evidence supporting a role for somatic mutations in the variable region of the lambda 2 chain of M315.

Authors:  N Sakato; T Azuma; H Fujio
Journal:  Immunology       Date:  1986-11       Impact factor: 7.397

9.  T helper cells recognize an idiotope located on peptide 88-114/117 of the light chain variable domain of an isologous myeloma protein (315).

Authors:  T Jørgensen; B Bogen; K Hannestad
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.